Skip to Content

  • Search

View Additional Section Content

A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK – 8931 in Subjects with Mild to Moderate Alzheimer’s Disease MK – 8931-017-03

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT01739348?term=nct01739348&rank=1

Clinical Trial Categories

  • Alzheimer's Disease
Contact
Jennifer McGowan at 215-327-0161

Location

  • Abington Neurological Associates, Ltd

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details